Literature DB >> 2695380

Immunohistochemical localization of acetaminophen-bound liver proteins.

J B Bartolone1, S D Cohen, E A Khairallah.   

Abstract

A sensitive immunofluorescence assay was developed for localizing acetaminophen (APAP) protein adducts in liver sections from treated mice. Affinity-purified anti-APAP antibodies, when applied to liver sections from mice given 600 mg APAP/kg, po, were preferentially localized in cells of the centrilobular region. At 30 min after dosing, covalently bound APAP was detected only in those cells most proximal to the central vein. Thereafter, binding spread throughout the centrilobular zone. However, by 8 hr the overall intensity of staining decreased and binding appeared more diffuse. Western blot analysis of electrophoretically resolved proteins from similarly treated mice revealed a corresponding temporal arylation of cytosolic proteins by APAP and indicated that the fluorescence detected at 30 min was associated with arylation of protein(s) of 44 kDa. The findings demonstrate the sensitivity and utility of immunohistochemical techniques in the study of covalently bound toxicants and emphasizes the temporal link between selective protein arylation in individually targetted cells to the development of APAP hepatotoxicity.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2695380     DOI: 10.1016/0272-0590(89)90339-4

Source DB:  PubMed          Journal:  Fundam Appl Toxicol        ISSN: 0272-0590


  8 in total

1.  Genes encoding the acetaminophen and selenium binding proteins map to mouse chromosome 3.

Authors:  C L Navarro; S D Cohen; E A Khairallah
Journal:  Mamm Genome       Date:  1996-12       Impact factor: 2.957

Review 2.  Current issues with acetaminophen hepatotoxicity--a clinically relevant model to test the efficacy of natural products.

Authors:  Hartmut Jaeschke; Mitchell R McGill; C David Williams; Anup Ramachandran
Journal:  Life Sci       Date:  2011-02-04       Impact factor: 5.037

3.  Polyinosinic-polycytidylic acid suppresses acetaminophen-induced hepatotoxicity independent of type I interferons and toll-like receptor 3.

Authors:  Amir A Ghaffari; Edward K Chow; Shankar S Iyer; Jane C Deng; Genhong Cheng
Journal:  Hepatology       Date:  2011-06       Impact factor: 17.425

4.  Gap junction inhibition prevents drug-induced liver toxicity and fulminant hepatic failure.

Authors:  Suraj J Patel; Jack M Milwid; Kevin R King; Stefan Bohr; Arvin Iracheta-Vellve; Arvin Iracheta-Velle; Matthew Li; Antonia Vitalo; Biju Parekkadan; Rohit Jindal; Martin L Yarmush
Journal:  Nat Biotechnol       Date:  2012-01-15       Impact factor: 54.908

5.  Immunohistochemical localization and quantification of the 3-(cystein-S-yl)-acetaminophen protein adduct in acetaminophen hepatotoxicity.

Authors:  D W Roberts; T J Bucci; R W Benson; A R Warbritton; T A McRae; N R Pumford; J A Hinson
Journal:  Am J Pathol       Date:  1991-02       Impact factor: 4.307

Review 6.  Translational biomarkers of acetaminophen-induced acute liver injury.

Authors:  Richard D Beger; Sudeepa Bhattacharyya; Xi Yang; Pritmohinder S Gill; Laura K Schnackenberg; Jinchun Sun; Laura P James
Journal:  Arch Toxicol       Date:  2015-05-17       Impact factor: 5.153

7.  A Novel Resolvin-Based Strategy for Limiting Acetaminophen Hepatotoxicity.

Authors:  Suraj J Patel; Jay Luther; Stefan Bohr; Arvin Iracheta-Vellve; Matthew Li; Kevin R King; Raymond T Chung; Martin L Yarmush
Journal:  Clin Transl Gastroenterol       Date:  2016-03-17       Impact factor: 4.488

8.  A computational model of liver tissue damage and repair.

Authors:  Priyom Adhyapok; Xiao Fu; James P Sluka; Sherry G Clendenon; Victoria D Sluka; Zemin Wang; Kenneth Dunn; James E Klaunig; James A Glazier
Journal:  PLoS One       Date:  2020-12-21       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.